Filter
742
Filtered Results: 742
Text search:
drug
manufacturing
Featured
Recommendations
59
New Publications
191
Language
Document type
No document type
372
Studies & Reports
143
Guidelines
124
Manuals
36
Strategic & Response Plan
35
Fact sheets
11
Situation Updates
10
Training Material
5
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
India
37
Kenya
32
Global
30
Ghana
20
Nigeria
20
Ethiopia
20
Uganda
19
Western and Central Europe
14
Sierra Leone
13
Bangladesh
13
South Africa
13
Nepal
12
Tanzania
12
Zambia
12
Africa
10
Lesotho
9
Malawi
9
Botswana
9
Ukraine
8
Zimbabwe
8
Liberia
8
South–East Asia Region
7
Namibia
7
Myanmar / Burma
7
Rwanda
6
Philippines
6
Latin America and the Carribbean
6
Eastern Europe
5
Indonesia
5
Eswatini/ Swaziland
4
Tajikistan
3
Thailand
3
Albania
3
Haiti
3
Cambodia
3
West and Central Africa
3
East and Southern Africa
3
Russia
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
Asia
2
Germany
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Moldova
2
Sudan
2
Pakistan
2
Serbia
1
Australia
1
Benin
1
China
1
Syria
1
Burkina Faso
1
Uzbekistan
1
Mongolia
1
Guinea
1
USA
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Turkmenistan
1
Maldives
1
Mauritius
1
Southern Africa
1
Vietnam
1
Brazil
1
Sri Lanka
1
South Sudan
1
Iraq
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
307
Clinical Guidelines
60
Pharmacy & Technologies
31
Public Health
30
Key Resources
18
Women & Child Health
13
Capacity Building
5
Toolboxes
Pharmacy
86
AMR
85
COVID-19
54
HIV
49
TB
38
Mental Health
34
Planetary Health
17
Rapid Response
14
Ebola
14
NTDs
14
NCDs
14
Global Health Education
12
Health Financing Toolbox
9
Specific Hazards
6
Caregiver
6
Conflict
5
Cholera
4
Natural Hazards
3
Polio
2
Refugee
1
Disability
1
Zika
1
As a global community of +750 representatives of the world’s civil society, the C20 official Engagement Group of the G20 is submitting a list of policy priorities for the upcoming G20 Finance Ministers & Central Bank Governors meeting on July 18th and the G20 Extraordinary Sherpa Meeting on July 2...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
As we approach World Asthma Day on the May 2, 2023, we reflect on the theme “ Asthma Care for All”. Prevalence of Asthma is increasing amongst children, adolescents and adults. Under-diagnosis, underutilization of inhaled corticosteroids, inaccessibility of treatment, and unaffordability of medi...
doi: https://doi.org/10.1101/2020.11.30.20236570
Pre-Print Article
A feasibility study in five African sites
Policy Brief
Accessed: 20.11.2019
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
The authors conduct an integrated survey of Antimicrobial Resistant Organisms (AMR) in drinking water, wastewater and surface water in three settings in Bangladesh: rural households, rural poultry farms, and urban food markets. Results show that untreated water discharged from rural households, poul...
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
Medicinal plants occupied an important position in the socio-cultural, spiritual and medicinal arena of rural people of India. T
The present report is based on contribution made by members of the task force and many other experts on medicinal plants. We hope the report on implementation will promot...
At the forefront of DNDi’s efforts to develop new treatments is the need to understand the realities and treatment needs of patients and health care staff in the field. The ultimate goal for human African trypanosomiasis (HAT) is a truly simplified
treatment which can be orally administered, impl...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,...
Dermatological Preparations For The Tropics
recommended
A formulary of dermatological preparations and background information on therapeutic choices, production and dispensing. 2nd edition
2nd edition. Essential guideline for humanitarian assistance
Report of a WHO technical consultation meeting
Ouagadougou, Burkina Faso
